It was always going to be old news given it is a summary of the "Operational and Financial Highlights for Quarter Ended September 30, 2022" ... not sure I would read too much into it but each to their own .... I wasn't expecting anything "new" as like the 2nd October Remestemcel-L announcement I believe 'new news' will come in the form of a separate ASX announcement
At least they didn't say they now intend to meet with the FDA in 2023 re: CHF ?
GLTAH
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-12
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.05 |
Change
0.080(8.25%) |
Mkt cap ! $1.198B | |||
| Open | High | Low | Value | Volume |
| 99.5¢ | $1.06 | 99.0¢ | $4.930M | 4.779M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 23545 | $1.05 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.05 | 339479 | 5 |
View Market Depth
| Last trade - 16.10pm 04/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |